Material compatibility of human albumin
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 8
Abstract
Objective To investigate the compatibility of human albumin and its internal packaging materials of Sinopharm Lanzhou Biopharmaceutical Co., Ltd. Methods One batch of inner packaging materials (medium borosilicate glass-molded injection bottle and halogenated butyl rubber plug for injection) was extracted with 4 extraction solvents to conduct the toxicological evaluation of potential inner packaging extracts. Through the simulated acceleration test, the trend analysis of the elements in the sample and the inner surface of the glass bottle were observed, and the routine drug inspection items during the long-term stability test process were determined. Results The detection results of the leaching elements of the internal packaging materials did not exceed the limit of 50%, and the organic matter safety threshold (margin of safety, MOS) was greater than 1.0, indicating that both the leaching elements and the organic matter had no safety risk to the user under the current exposure. The results of the simulated acceleration test show that the drug will not have the risk of peeling tablets after the long-term stability condition was placed for a period of time, and the routine inspection items of the long-term stability test drugs all meet the requirements of the pharmacopoeia. Conclusion The inner packaging material has no significant impact on the quality of drugs and has good overall compatibility, making it suitable for packaging human albumin.
Authors and Affiliations
Yali WANG, Junhui WEI, Meichun YANG, Xiaojuan ZHOU, He REN, Sha LI, Nan XIE
Keywords
Related Articles
- EP ID EP738609
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.08.006
- Views 44
- Downloads 0
Study on separation and purification process of C1 esterase inhibitor
Objective To study the technology of separating and purifying C1 esterase inhibitor (C1-INH) by using the waste washing liquid as raw materia during the preparation of human prothrombin complex (PCC) l. Methods C1-INH wa...
Efficacy and safety evaluation of plasma-derived human coagulation factor Ⅷ in patients with hemophilia A
Objective To evaluate the efficacy and safety of plasma-derived human coagulation factor Ⅷ (FⅧ) in the treatment of patients with hemophilia A. Methods A multi-center and open, SAT(single-arm trials) clinical study was c...
Preliminary discussion on the causes and influencing factors of blood discarding
Objective To conduct a retrospective statistical analysis of the blood discarding situation in Xuzhou Central Blood Station in the past 5 years, so as to explore relevant measures and strategies to reduce blood discardin...
Status analysis of informed consent of blood donors based on content analysis
Objective To understand the current status and shortcomings of the informed consent of blood donors, and to ensure that the informed consent of blood donors complies with ethical norms and management requirements. Method...
Recruitment strategies of blood donors during the COVID-19 epidemic
Objective To explore the recruitment strategy of blood donors under the situation of blood supply shortage during the COVID-19 epidemic. Methods The theory of planned behavior and the stage change model of behavior were...